Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Catabolism of human γG-immunoglobulins of different heavy chain subclasses: I. Catabolism of γG-myeloma proteins in man
Hans L. Spiegelberg, … , Ben G. Fishkin, Howard M. Grey
Hans L. Spiegelberg, … , Ben G. Fishkin, Howard M. Grey
Published October 1, 1968
Citation Information: J Clin Invest. 1968;47(10):2323-2330. https://doi.org/10.1172/JCI105917.
View: Text | PDF
Article has an altmetric score of 3

Catabolism of human γG-immunoglobulins of different heavy chain subclasses: I. Catabolism of γG-myeloma proteins in man

  • Text
  • PDF
Abstract

The rates of catabolism of human γG-immunoglobulins of subclasses γG1, γG2, γG3, and γG4 were studied by determining the rates of elimination from the circulation of pairs of 131I-and 125I-labeled γG-myeloma proteins in 57 patients suffering from cancer other than multiple myeloma. On the average, γG1-, γG2-, and γG4-myeloma proteins were catabolized at a rate similar to that of normal γG-immunoglobulin, whereas γG3-myeloma proteins were catabolized more rapidly than normal γG-immunoglobulin. The average half-lives for the myeloma proteins were 12.3 days for normal γG, 11.6 days for γG1, 12.4 days for γG2, 8.2 days for γG3, and 11.3 days for γG4. However, significant differences in catabolic rates were observed when individual myeloma proteins of a single subclass were compared. These individual variations were present within all four heavy chain subclasses. The extent of differences ranged from 10 to 47%. The catabolic rate of normal γG was in an intermediate range when compared with myeloma proteins of relatively long and short half-lives. The rate of catabolism of an individual myeloma protein did not correlate with its light chain type, Gm factor, carbohydrate content, or electrophoretic mobility. These findings indicate that the structure(s) related to the catabolism of γG-immunoglobulins are complex and differ from one immunoglobulin molecule to another.

Authors

Hans L. Spiegelberg, Ben G. Fishkin, Howard M. Grey

×

Total citations by year

Year: 2019 2017 2016 2015 2013 2012 2011 2010 2004 2001 2000 1996 1995 1994 1993 1992 1991 1990 1989 1987 1985 1984 1983 1980 1979 1977 1976 1975 1974 1973 1972 1971 1970 1969 Total
Citations: 2 1 1 1 2 2 3 1 1 1 1 1 1 2 1 2 3 2 1 2 1 2 1 2 1 3 1 2 7 5 5 5 7 1 74
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (74)

Title and authors Publication Year
IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies
W Bi, W Xu, L Cheng, J Xue, Q Wang, F Yu, S Xia, Q Wang, G Li, C Qin, L Lu, L Su, S Jiang, KJ Doores
PLoS pathogens 2019
Biomarkers of Human Aging
A Moskalev
2019
Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera
M Verma, N Suryanarayana, U Tuteja, K Thavachelvam, MK Rao, R Bhargava, S Shukla
Toxicon : official journal of the International Society on Toxinology 2017
Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen
F Selis, G Focà, A Sandomenico, C Marra, CD Mauro, GS Jotti, S Scaramuzza, A Politano, R Sanna, M Ruvo, G Tonon
International journal of molecular sciences 2016
Human plasma protein N-glycosylation
F Clerc, KR Reiding, BC Jansen, GS Kammeijer, A Bondt, M Wuhrer
Glycoconjugate Journal 2015
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
MM Schmidt, SA Townson, AJ Andreucci, BM King, EB Schirmer, AJ Murillo, C Dombrowski, AW Tisdale, PA Lowden, AL Masci, JT Kovalchin, DV Erbe, KD Wittrup, ES Furfine, TM Barnes
Structure 2013
Molecular and Cellular Mechanisms of Antibody Activity
F Nimmerjahn
2013
Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations
CA Boswell, D Bumbaca, PJ Fielder, LA Khawli
The AAPS Journal 2012
Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life
JT Andersen, S Foss, VE Kenanova, T Olafsen, IS Leikfoss, DC Roopenian, AM Wu, I Sandlie
The Journal of biological chemistry 2012
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Endoglin-Targeted Cancer Therapy
Ben K. Seon, Akinao Haba, Fumihiko Matsuno, Norihiko Takahashi, Masanori Tsujie, Xinwei She, Naoko Harada, Shima Uneda, Tomoko Tsujie, Hirofumi Toi, Hilda Tsai, Yuro Haruta
Current Drug Delivery 2011
Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing
CD Davis, UM Hanumegowda
Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing 2010
Lupus-Derived Antiprothrombin Autoantibodies from a V Gene Phage Display Library Are Specific for the Kringle 2 Domain of Prothrombin
A Le, S Dasgupta, S Planque, S Paul, P Thiagarajan
Biochemistry 2004
Radioimmunotherapy with Iodine-131 Tositumomab in Patients with Low-Grade Non-Hodgkin's B-Cell Lymphoma Does Not Induce Loss of Acquired Humoral Immunity against Common Antigens
T Nordøy, A Kolstad, MK Tuck, IS Aaberge, A Husebekk, MS Kaminski
Clinical Immunology 2001
Monoclonal Antibody Light Chain with Prothrombinase Activity
P Thiagarajan, R Dannenbring, K Matsuura, A Tramontano, G Gololobov, S Paul
Biochemistry 2000
Igg Subclasses in Capd Patients
RT Krediet, GC Koomen, A Vlug, DG Struijk, B Buis, RW Olden, AL Imholz
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1996
The introduction of human monoclonal anti-D for therapeutic use
A Fletcher, A Thomson
Transfusion Medicine Reviews 1995
Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers
J Goodrick, B Kumpel, D Pamphilon, I Fraser, G Chapman, B Dawes, D Anstee
Clinical & Experimental Immunology 1994
Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.
Goodrick J, Kumpel B, Pamphilon D, Fraser I, Chapman G, Dawes B, Anstee D
Clinical & Experimental Immunology 1994
Half-life of the maternal IgG1 allotype in infants
H Sarvas, I Seppl, S Kurikka, R Siegberg, O Mkel
Journal of Clinical Immunology 1993
Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting C1q and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse
EJ Wawrzynczak, S Denham, GD Parnell, AJ Cumber, PT Jones, G Winter
Molecular Immunology 1992
Immunoglobulin G subclasses in human colostrum, milk and saliva
K Kim, MA Keller, DC Heiner
Acta Paediatrica 1992
IgG subclass deficiency
A Ferrante, LJ Beard, DM Roberton
Pediatric Allergy and Immunology 1991
Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva
T Ogawa, Y Kono, ML McGHEE, JR McGHEE, JE Roberts, S Hamada, H Kiyono
Clinical & Experimental Immunology 1991
Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva.
Ogawa T, Kono Y, McGhee ML, McGhee JR, Roberts JE, Hamada S, Kiyono H
Clinical & Experimental Immunology 1991
Multiple infusions of human intravenous immunoglobulin in chimpanzees do not lead to immune elimination
H Leibl, HM Wolf, G Eder, JW Mannhalter, MM Eibl
Clinical & Experimental Immunology 1990
Multiple infusions of human intravenous immunoglobulin in chimpanzees do not lead to immune elimination.
Leibl H, Wolf HM, Eder G, Mannhalter JW, Eibl MM
Clinical & Experimental Immunology 1990
Immunologic and pharmacologic concepts of monoclonal antibodies
LS Zuckier, LD Rodriguez, MD Scharff
Seminars in Nuclear Medicine 1989
Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice
PJ Talbot, MJ Buchmeier
Immunology 1987
IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays
TE Michaelsen, L Kornstad
Clinical & Experimental Immunology 1987
Immunoglobulin subclass distribution of synovial plasma cells in rheumatoid arthritis determined by use of monoclonal anti-subclass antibodies
PL Haber, H Kubagawa, WJ Koopman
Clinical Immunology and Immunopathology 1985
IgG Subclass Concentrations in Preterm Neonates
VA Oxelius, NW Svenningsen
Acta Paediatrica 1984
Immunodermatology
RE Schopf, M Jung, B Morsches, K Bork
Immunodermatology 1984
Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar rates
JA Schifferli, N Amos, CD Pusey, JG Sissons, DK Peters
Clinical & Experimental Immunology 1983
Human IgG subclasses in health and disease (A review)Part I
F Shakib, DR Stanworth
La Ricerca in Clinica e in Laboratorio 1980
IgG Subclass Defficiency and Its Relation to IgA Deficiency
VA Oxelius, B Lindquist
Pediatrics International 1980
In vivo metabolism of a monoclonal IgG cryoglobulin
GN Abraham, C Waterhouse, JJ Condemi
Clinical & Experimental Immunology 1979
Metabolism of Autologous and Homologous IgG in Rheumatoid Arthritis
MA Catalano, EH Krick, DH de Heer, RM Nakamura, AN Theofilopoulos, JH Vaughan
Journal of Clinical Investigation 1977
Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F(ab‘)2fragments on a cholinergic receptor preparation from Torpedo marmorata
AK Lefvert, K Bergström
European Journal of Clinical Investigation 1977
Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit
TE Michaelsen, B Frangione, EC Franklin
The Journal of biological chemistry 1977
Ultracentrifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement
VN Schumaker, MA Calcott, HL Spiegelberg, HJ Mueller-Eberhard
Biochemistry 1976
Human myeloma IgG half-molecules. Catabolism and biological properties
HL Spiegelberg
Journal of Clinical Investigation 1975
The Antibody Molecule
A Nisonoff, JE Hopper, SB Spring
The Antibody Molecule 1975
Plasma Protein Metabolism
S Jarnum
Acta Anaesthesiologica Scandinavica 1974
IgG Subclasses: Relationship to Clinical Aspects of Multiple Myeloma and Frequency Distribution among M-Components
PH Schur, RA Kyle, KJ Bloch, WJ Hammack, SL Rivers, A Sargent, RF Ritchie, OR McIntyre, WC Moloney, L Wolfson
Scandinavian Journal of Haematology 1974
Complement-Fixing and Lymphocytotoxic Antibodies in Serum of Pregnant Women at Delivery
G Nymand
Vox Sanguinis 1974
Immunoglobulin classes, IgG subclasses, Gm genetic markers, and Clq following bone marrow transplantation in X-linked combined immunodeficiency
WJ Yount, PD Utsinger, RA Gatti, RA Good
The Journal of Pediatrics 1974
Clinical Immunobiology
LE Spitler, AS Levin, HH Fudenberg
Clinical Immunobiology 1974
The Immunoglobulin a System
J Mestecky, AR Lawton
1974
Unusual Molecular Properties of Human IgG3 Proteins Due to an Extended Hinge Region
TE Michaelsen, JB Natvig
The Journal of biological chemistry 1974
Release of Serotonin from Human Platelets Induced by Aggregated Immunoglobulins of Different Classes and Subclasses
PM Henson, HL Spiegelberg
Journal of Clinical Investigation 1973
Metabolic properties of human IgA subclasses
A Morell, F Skvaril, G Noseda, S Barandun
Clinical & Experimental Immunology 1973
Qualitative and quantitative studies on IgG2 globulins in individual human sera with an antiserum capable of differentiating between Gm(n+) and Gm(n-) proteins
M der Giessen, W Freyee, E Rossouw, E Loghem
Clinical & Experimental Immunology 1973
Heavy chain subclass of human anti-platelet antibodies
S Karpatkin, PH Schur, N Strick, GW Siskind
Clinical Immunology and Immunopathology 1973
Immunoglobulin Disturbances and Their Clinical Significance
A Solomon, CL McLaughlin
Medical Clinics of North America 1973
The γG subclass of antinuclear and antinucleic acid antibodies
PH Schur, M Monroe, N Rothfield
Arthritis & Rheumatism 1972
The hinge region of IgG3, an extended part of the molecule
TE Michaelsen, JB Natvig
FEBS Letters 1972
IgG3 levels in patients with chronic membranoproliferative glomerulonephritis
RA Thompson
British medical journal 1972
The catabolism of human G immunoglobulins of different heavy chain subclasses. 3. The catabolism of heavy chain disease proteins and of Fc fragments of myeloma proteins
HL Spiegelberg, BG Fishkin
Clinical & Experimental Immunology 1972
IgG subclasses: Development of the serum concentrations in “normal” infants and children
A Morell, F Skvaril, WH Hitzig, S Barandun
The Journal of Pediatrics 1972
Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its interaction with an IgG-reactive monoclonal IgM
TA Waldmann, JS Johnson, N Talal
Journal of Clinical Investigation 1971
Degradation of IgG3 monoclonal proteins during storage and in the presence of a thiol (dl-penicillamine)
G Virella
Experientia 1971
Human IgG Subclasses in Maternal and Fetal Serum
A Morell, F Skvaril, E Loghem, M Kleemola
Vox Sanguinis 1971
Metabolism of radio-iodinated IgG in patients with abnormal IgG levels. I. Hypergamma-globulinaemia
JV Wells, HH Fudenberg
Clinical & Experimental Immunology 1971
Placental transfer of a human IgG2 monoclonal protein
G Virella, AD Pascale, U Lippi
Experientia 1971
Aggregation of γG3 proteins: relevance to the hyperviscosity syndrome
JD Capra, HG Kunkel
Journal of Clinical Investigation 1970
Metabolic properties of IgG subclasses in man
A Morell, WD Terry, TA Waldmann
Journal of Clinical Investigation 1970
Altered immunoglobulin metabolism in systemic lupus erythematosus and rheumatoid arthritis
J Levy, EV Barnett, NS MacDonald, JR Klinenberg
Journal of Clinical Investigation 1970
Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia
WJ Yount, M Seligmann, R Hong, R Good, HG Kunkel
Journal of Clinical Investigation 1970
Anti-Rh Activity of Human γG4 Proteins
M Frame, PL Mollison, WD Terry
Nature 1970
Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins
G Virella, MF Lopes-Virella
Clinical & Experimental Immunology 1970
Catabolism of gamma G-globulin and myeloma proteins of the subclasses gamma G1 and gamma G2 in a healthy volunteer
J Watkins, DE Tee
Immunology 1970
Protides of the Biological Fluids
PA Small, RH Waldman
Protides of the Biological Fluids 1969

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 9 patents
9 readers on Mendeley
See more details